The cellular infiltration of NK cells was enhanced by targeting NKG2D and its ligands MICA and MICB, resulting in a more-efficient destruction of CRC spheroids and demonstrating their potential for anti-cancer therapies. This evidence concerns the gene MICA and colorectal carcinoma.